Skip to main content

Seer, Inc. (SEER)

NASDAQ: SEER · IEX Real-Time Price · USD
33.48 -1.01 (-2.93%)
Oct 22, 2021 4:00 PM EDT - Market closed
Market Cap2.06B
Revenue (ttm)1.80M
Net Income (ttm)n/a
Shares Out60.84M
EPS (ttm)-1.40
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume239,935
Open34.37
Previous Close34.49
Day's Range32.95 - 34.37
52-Week Range26.48 - 86.55
Betan/a
AnalystsBuy
Price Target55.00 (+64.3%)
Est. Earnings DateNov 9, 2021

About SEER

Seer, Inc., a life sciences company, engages in developing and commercializing products for researchers to unlock biological information. The company develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that provides workflow to make proteomic profiling, and the analysis of the samples needed to characterize the nature of the proteome. It intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as...

IndustryLife Sciences Tools & Services
IPO DateDec 4, 2020
Employees60
Stock ExchangeNASDAQ
Ticker SymbolSEER
Full Company Profile

Financial Performance

In 2020, Seer, Inc's revenue was $656,000, an increase of 465.52% compared to the previous year's $116,000. Losses were -$32.78 million, 104.4% more than in 2019.

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for Seer, Inc stock is "Buy." The 12-month stock price forecast is 55.00, which is an increase of 64.28% from the latest price.

Price Target
$55.00
(64.28% upside)
Analyst Consensus: Buy

News

Seer to Report Third Quarter Financial Results on November 9, 2021

REDWOOD CITY, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financ...

1 week ago - GlobeNewsWire

Seer to Present at the Morgan Stanley Global Healthcare Conference

REDWOOD CITY, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be particip...

1 month ago - GlobeNewsWire

Seer Reports Second Quarter 2021 Financial Results

Expanded installed base and booked initial revenue for Proteograph Product Suite Expanded installed base and booked initial revenue for Proteograph Product Suite

2 months ago - GlobeNewsWire

Seer Bio Partners with Enlight Medical to Commercialize the Proteograph™ Product Suite in China

REDWOOD CITY, Calif. and BEIJING, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it has sig...

2 months ago - GlobeNewsWire

Earnings Previews: Airbnb, ContextLogic, Disney, Seer, SoFi

Of a dozen firms that reported earnings before markets opened on Wednesday, eight beat estimates and four missed.

Other symbols:ABNBDISSOFIWISH
2 months ago - 24/7 Wall Street

Seer to Report Second Quarter Financial Results on August 12, 2021

REDWOOD CITY, Calif., July 13, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financ...

3 months ago - GlobeNewsWire

Biodesix Announces Presentation on Novel Proteomic Techniques in Partnership with Seer

BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, today announced in partnership with Seer, Inc. (NASDAQ: SEER)...

Other symbols:BDSX
4 months ago - Business Wire

Seer Reports First Quarter 2021 Financial Results

Second Phase of Commercialization Advances with the Addition of Multiple Limited Release Customers

5 months ago - GlobeNewsWire

Seer to Present at the BofA Securities 2021 Healthcare Conference

REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be participat...

5 months ago - GlobeNewsWire

Seer to Report First Quarter Financial Results on May 10, 2021

REDWOOD CITY, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report fina...

6 months ago - GlobeNewsWire

Seer and SCIEX Sign Commercial Agreement to Offer End-to-End Unbiased Proteomics Solutions

Seer Proteograph™ Product Suite combined with SCIEX mass spectrometry technology to provide unbiased, deep proteomics workflows for labs of all types Seer Proteograph™ Product Suite combined with SCIEX ...

6 months ago - GlobeNewsWire

Seer Reports Fourth Quarter and Full Year 2020 Financial Results and Fuels Commercial Progress in 2021 with New Colla...

Added Salk Institute as collaboration customer and SCIEX as new commercial partner Added Salk Institute as collaboration customer and SCIEX as new commercial partner

6 months ago - GlobeNewsWire

Seer to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021

REDWOOD CITY, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report fina...

7 months ago - GlobeNewsWire

Top 4th-Quarter Buys of Lee Ainslie's Maverick Capital

Lee Ainslie (Trades, Portfolio), the founder and CEO of Maverick Capital, recently disclosed the firm's portfolio changes for the fourth quarter of 2020, which ended on Dec. 31.

Other symbols:AMATFLTMGM
7 months ago - GuruFocus

Seer to Present at the Cowen 41st Annual Healthcare Conference

REDWOOD CITY, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be participa...

7 months ago - GlobeNewsWire

Seer Announces Closing of Public Offering of Common Stock

REDWOOD CITY, Calif. , Feb. 01, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the closing of an underwritten publ...

8 months ago - GlobeNewsWire

Seer Announces Pricing of Upsized Public Offering of Common Stock

REDWOOD CITY, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the pricing of an underwritten publi...

8 months ago - GlobeNewsWire

Seer Announces Proposed Public Offering of Common Stock

REDWOOD CITY, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the commencement of a proposed under...

8 months ago - GlobeNewsWire

Seer Signs Commercial Agreement to Provide Complete End-to-End Solution for Unbiased, Deep, Rapid and Large-Scale Pro...

Combination of Thermo Fisher's market leading Orbitrap mass spectrometer portfolio with Seer Proteograph™ Product Suite to expand availability of end-to-end proteomics in new markets Combination of Ther...

9 months ago - GlobeNewsWire

Seer to Present at the 39th Annual J.P. Morgan Healthcare Conference

REDWOOD CITY, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid ...

9 months ago - GlobeNewsWire

Notable Insider Buys Of the Past Week: Avis Budget, Biotech IPOs And More

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. So insider buying can ...

Other symbols:CARARDXCNNEMPLNSBTX
10 months ago - Benzinga

Seer Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Sh...

REDWOOD CITY, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable pr...

10 months ago - GlobeNewsWire

Biotech IPOs Stay Hot With Seer, Silverback Set To Trade

The hot category of initial public offerings in the biotechnology sector continues, with two set to trade Friday: Seer and Silverback Therapeutics. Both priced above their estimated range.

Other symbols:SBTX
10 months ago - Investors Business Daily

Seer Announces Pricing of Initial Public Offering

REDWOOD CITY, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company focused on enabling exceptional scientific outcomes through the power of unbiased, deep, rapid and scalable pr...

10 months ago - GlobeNewsWire